A compound that blocks a key inflammatory pathway in the brain reverses cognitive decline in mice.
“This, in turn, activates the transforming growth factor-beta (TGF-ß) signaling pathway, which drives a pro-inflammatory environment and compromises cognitive function. Roughly two-thirds of all adults over the age of 70 years have some degree of BBB dysfunction.”